The Journal of thoracic and cardiovascular surgery
-
J. Thorac. Cardiovasc. Surg. · Jul 1994
Randomized Controlled Trial Clinical TrialEffect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study.
The prophylactic use of aprotinin has recently been reported to be associated with a significant decrease in blood loss in patients undergoing cardiopulmonary bypass procedures. One of the primary effects of aprotinin is prevention of plasmin degradation of platelet function. Because aprotinin is commercially unavailable in the United States at this time, we evaluated epsilon-aminocaproic acid with respect to decreased perioperative blood loss. ⋯ None of the patients had a perioperative myocardial infarction or cerebrovascular accident. The prophylactic administration of epsilon-aminocaproic acid results in a significant decrease in blood loss in patients undergoing first-time coronary artery bypass grafting, and blood transfusion requirements are significantly less. It may be important to administer epsilon-aminocaproic acid before skin incision to be optimally effective.
-
J. Thorac. Cardiovasc. Surg. · Jul 1994
Determinants of operative mortality in elderly patients undergoing coronary artery bypass grafting. Emphasis on the influence of internal mammary artery grafting on mortality and morbidity.
Coronary artery bypass grafting has been performed for elderly patients (> or = 70 years) with increasing frequency. From January 1986 through June 1993, 1399 elderly patients underwent isolated coronary bypass grafting. Of these patients, 823 had saphenous vein grafts alone and 576 had internal mammary artery grafting, including unilateral (n = 546) and bilateral (n = 28). ⋯ Significant variables (age, gender, height, weight, surface area, diabetes, obesity, body mass index, history of congestive heart failure, myocardial infarction, or arrhythmia, functional class, left ventricular ejection fraction, stenosis of the left anterior descending or right coronary artery, emergency operation, reoperation, number of grafts, perfusion time, and bilateral or right internal mammary artery grafting) were included in a stepwise multiple logistic regression analysis. The logistic regression demonstrates that those preoperative (history of congestive heart failure or myocardial infarction, low ejection fraction, female gender, and old age), intraoperative (long cardiopulmonary bypass time, emergency operation, reoperation, and use of right internal mammary artery grafting), and postoperative (postoperative complications) variables are independently associated with higher mortality. This study reveals the high-risk groups in elderly patients undergoing coronary bypass and suggests that a left internal mammary artery graft in combination with saphenous vein grafting may achieve a lower operative mortality and morbidity than other procedures in selected elderly patients undergoing coronary artery bypass grafting.
-
J. Thorac. Cardiovasc. Surg. · Jul 1994
Complement, leukocytes, and leukocyte elastase in full-term neonates undergoing cardiac operation.
In 13 neonates undergoing cardiac operations for congenital cardiac defects, complement, leukocytes, and leukocyte elastase were studied during and after cardiopulmonary bypass. All but two neonates received prostaglandin E1 before the operation. The C3d/C3 ratio rose significantly during cardiopulmonary bypass from 0.86 +/- 0.55 to 1.40 +/- 0.56 (mean +/- standard deviation; p < 0.0001). ⋯ Elastase release occurred in all neonates during cardiopulmonary bypass and averaged 331.5 +/- 175.7 micrograms/L. Complement activation and leukocyte stimulation did not correlate with postoperative complications or outcome. This study demonstrates complement activation and leukocyte stimulation in neonates undergoing cardiac operation.
-
J. Thorac. Cardiovasc. Surg. · Jul 1994
The effect of pulsatile perfusion on cerebral blood flow during profound hypothermia with total circulatory arrest.
In 39 mongrel dogs, regional cerebral blood flow was measured during pulsatile and nonpulsatile deep hypothermic cardiopulmonary bypass with total circulatory arrest. Total circulatory arrest was performed at 20 degrees C cerebral temperature for 40 minutes in 15 dogs, 60 minutes in 12 dogs, and 80 minutes in 12 dogs. Cerebral blood flow in both groups decreased as cerebral temperature fell and there was no significant difference in cerebral blood flow between the two groups during the cooling period. ⋯ After circulatory arrest for 60 minutes, cerebral blood flow in the pulsatile group increased to 141.8% +/- 16.1% of its initial value when the cerebral temperature became 35 degrees C, but it remained significantly lower (64.5% +/- 9.2%) in the nonpulsatile group (p < 0.01). After circulatory arrest for 80 minutes, cerebral blood flow in both groups remained lower than the respective initial values. These results suggest that pulsatile perfusion maintains cerebral blood flow even during profound hypothermia and that it may protect the brain from ischemic and hypoxic damage caused by profound hypothermia and total circulatory arrest in cardiac operations.
-
J. Thorac. Cardiovasc. Surg. · Jun 1994
Comparative StudyComparison of saphenous vein graft relaxation between Plasma-Lyte solution and normal saline solution.
Venospasm of saphenous vein grafts may damage endothelial cells and compromise early and late graft performance. Hence it is desirable to identify and use storage solutions that minimize vascular spasm during vein preparation. In view of this, we initiated isometric tension-recording studies in isolated canine and human saphenous vein to evaluate the acute, vasoactive effects of two storage solutions, Plasma-Lyte solution and normal saline solution. ⋯ Finally, we tested the vasoactive effect of Plasma-Lyte solution on human saphenous vein obtained by discard from coronary bypass operations. Plasma-Lyte solution at 37 degrees C effectively dilated norepinephrine-activated human saphenous vein, inducing complete relaxation within 20 minutes. On this basis, we recommend the use of Plasma-Lyte solution as a venodilating storage solution during coronary bypass operations to optimize vein graft relaxation before implantation.